Phase 1 Acute Lymphoblastic Leukemia, Adult Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Acute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in Relapse
Essen Biotech75 enrolled1 locationNCT06213636
Recruiting
Phase 1Phase 2
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, Adult B-Cell
The First Affiliated Hospital of Soochow University34 enrolled1 locationNCT03984968
Recruiting
Phase 1
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc.36 enrolled5 locationsNCT06462365
Recruiting
Phase 1
Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
Acute Lymphoblastic Leukemia, AdultBurkitt LymphomaLymphoblastic Lymphoma, Adult
Fifth Affiliated Hospital, Sun Yat-Sen University28 enrolled1 locationNCT06060782
Recruiting
Phase 1Phase 2
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+3 more
University Hospital Heidelberg68 enrolled2 locationsNCT03676504